Dr. Michael Mithoefer



Michael Mithoefer, M.D., began collaborating with MAPS in 2000 on the first U.S. Phase 2 clinical trial of MDMA-assisted  psychotherapy.

He has since conducted two of the six MAPS-sponsored Phase 2 clinical trials testing MDMA-Assisted Psychotherapy for PTSD, as well a study providing MDMA-assisted  sessions for therapists who have completed the MAPS-sponsored  MDMA Therapy Training Program, and a pilot study treating couples  with MDMA-Assisted Psychotherapy combined with Cognitive-Behavioural Conjoint Therapy.

He is now Senior Medical Director for  Medical Affairs, Training and Supervision at MAPS Public Benefit Corporation (MAPS PBC). He is a Grof-certified Holotropic Breathwork Facilitator, is trained in EMDR and Internal Family Systems Therapy, and has nearly 30 years of experience treating trauma patients.

Sign Up for Newsletter


301-217 Queen St. W, Toronto, ON, M5V 0R2, Canada

1 Regent Street, Bristol, BS8 4HW, United Kingdom

© 2021 Awakn Life Sciences Corp      |      Privacy Policy      |      Appropriate Use Policy

Back to top Arrow